White Willow Bark Extract
Natural salicin source (BHA precursor)
Limited Data
Insufficient safety data available. Consider enriching this ingredient.
Details
Description
Natural salicin source (BHA precursor)
Purpose
Function
Natural salicin source (BHA precursor)
Profile
Properties
Silicone
Silicone free
Compliance
Regulatory Status
EU
Permitted
Safety
GOOD
US
Permitted
Absorptionlow
Sensitizationlow
MoSnot established
NOAEL1000 mg/kg
ConcernLow
Verdict
Willow bark extract (CAS 84082-82-6) is permitted in the EU and not restricted by the FDA for cosmetic use; CIR determined salicylates safe when formulated non-irritating and non-sensitizing, with Salix alba-specific assessment ongoing.
US Note
Not restricted by FDA for cosmetic use. CIR reviewed salicylates in 2019 -- safe when formulated non-irritating and non-sensitizing. Salix alba bark-specific CIR assessment ongoing (2024-2025, 1082 formulations, <=1.1% leave-on), not yet finalized.
Assessment
Ratings
Reference
Identifiers
No registry identifiers available for this ingredient.